ESGNX
Price
$21.08
Change
-$0.23 (-1.08%)
Updated
Feb 21 closing price
Net Assets
954.97M
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

ESGNX vs RNPHX

Header iconESGNX vs RNPHX Comparison
Open Charts ESGNX vs RNPHXBanner chart's image
Mirova Global Sustainable Equity N
Price$21.08
Change-$0.23 (-1.08%)
VolumeN/A
Net Assets954.97M
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
ESGNX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESGNX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESGNX is a Buy and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 148B vs. ESGNX (955M). RNPHX pays higher dividends than ESGNX: RNPHX (1.00) vs ESGNX (0.60). ESGNX was incepted earlier than RNPHX: ESGNX (8 years) vs RNPHX (9 years). ESGNX is a more actively managed with annual turnover of: 23.00 vs. RNPHX (17.00). RNPHX has a lower initial minimum investment than ESGNX: RNPHX (250) vs ESGNX (1000000). RNPHX annual gain was more profitable for investors over the last year : 10.58 vs. ESGNX (9.59). ESGNX (35.85) and RNPHX (34.72) have equivalent 5 years return.
ESGNXRNPHXESGNX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD4.9804.639107%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets955M148B1%
Annual Yield % from dividends0.601.0060%
Returns for 1 year9.5910.5891%
Returns for 3 years19.4414.84131%
Returns for 5 years35.8534.72103%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ABTS0.41-0.01
-2.14%
Abits Group
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp